CDH2 and benign prostatic hyperplasia: The present study did demonstrate that SV inhibited the EMT process in BPH-1 cells, in which the level of the epithelial marker E-cadherin was upregulated, while the levels of mesenchymal markers N-cadherin, Vimentin, and Snail were downregulated.